Identifying and Treating Young Patients at Risk for Cardiovascular Events
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 2018
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1117 Public Health and Health Services (FoR)
- Aged (MeSH)
- Aspirin (MeSH)
- Cardiovascular Diseases (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Double-Blind Method (MeSH)
- Drug Therapy, Combination (MeSH)
- Factor Xa Inhibitors (MeSH)
- Female (MeSH)
- Follow-Up Studies (MeSH)
- Humans (MeSH)
- Hydroxymethylglutaryl-CoA Reductase Inhibitors (MeSH)
- Lower Extremity (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Mortality (MeSH)
- Myocardial Infarction (MeSH)
- Peripheral Arterial Disease (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Registries (MeSH)
- Risk Factors (MeSH)
- Rivaroxaban (MeSH)
- Young Adult (MeSH)